Ali Tavakkoli

Ali Tavakkoli

Auto-generated profile, based on publicly available information

Ali Tavakkoli

Division of General and Gastrointestinal Surgery, Brigham and Women's Hospital, Boston, Massachusetts (A.T.)

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2018 in Nature Materials
Verified
Journal Article
Closed access
PDF file
YLYuhan Lee
Yuhan Lee
TDTara E. Deelman
Tara E. Deelman
KCKeyue Chen
Keyue Chen
DLDawn S. Y. Lin
Dawn S. Y. Lin
ATAli Tavakkoli
Ali Tavakkoli
JKJeffrey M. Karp
Jeffrey M. Karp

15 April 2018 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
JBJessie P. Bakker
Jessie P. Bakker
ATAli Tavakkoli
Ali Tavakkoli
MRMichael Rueschman
Michael Rueschman
WWWei Wang
Wei Wang
RARobert Andrews
Robert Andrews
SPSanjay Patel
Sanjay Patel

1 October 2022 in JAMA Surgery
Verified
Journal Article
Open access
PDF file
KCKaren J. Coleman
Karen J. Coleman
RWRobert Wellman
Robert Wellman
SFStephanie L. Fitzpatrick
Stephanie L. Fitzpatrick
MCMolly B. Conroy
Molly B. Conroy
CHCallie Hlavin
Callie Hlavin
WRWilliam S. Richardson
William S. Richardson
Importance: Bariatric surgery is the most effective treatment for severe obesity; yet it is unclear whether the long-term safety and comparative effectiveness of these operations differ across racial and ethnic groups.Objective: To compare outcomes of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) across racial and ethnic groups in the National Patient-Centered Clinical Research Network (PCORnet) Bariatric Study.Design, Setting, and Participants: This was a retrospective, observational, comparative effectiveness cohort study that comprised 25 health care systems in the PCORnet Bariatric Study. Patients were adults and adolescents aged 12 to 79 years who underwent a primary (first nonrevisional) RYGB or SG operation between January 1, 2005, and September 30, 2015, at participating health systems. Patient race and ethnicity included Black, Hispanic, White, other, and unrecorded. Data were analyzed from July 1, 2021, to January 17, 2022.Exposure: RYGB or SG.Outcomes: Percentage total weight loss (%TWL); type 2 diabetes remission, relapse, and change in hemoglobin A1c (HbA1c) level; and postsurgical safety and utilization outcomes (operations, interventions, revisions/conversions, endoscopy, hospitalizations, mortality, 30-day major adverse events) at 1, 3, and 5 years after surgery.Results: A total of 36 871 patients (mean [SE] age, 45.0 [11.7] years; 29 746 female patients [81%]) were included in the weight analysis. Patients identified with the following race and ethnic categories: 6891 Black (19%), 8756 Hispanic (24%), 19 645 White (53%), 826 other (2%), and 783 unrecorded (2%). Weight loss and mean reductions in HbA1c level were larger for RYGB than SG in all years for Black, Hispanic, and White patients (difference in 5-year weight loss: Black, −7.6%; 95% CI, −8.0 to −7.1; P < .001; Hispanic, −6.2%; 95% CI, −6.6 to −5.9; P < .001; White, −5.9%; 95% CI, −6.3 to −5.7; P < .001; difference in change in year 5 HbA1c level: Black, −0.29; 95% CI, −0.51 to −0.08; P = .009; Hispanic, −0.45; 95% CI, −0.61 to −0.29; P < .001; and White, −0.25; 95% CI, −0.40 to −0.11; P = .001.) The magnitude of these differences was small among racial and ethnic groups (1%-3% of %TWL). Black and Hispanic patients had higher risk of hospitalization when they had RYGB compared with SG (hazard ratio [HR], 1.45; 95% CI, 1.17-1.79; P = .001 and 1.48; 95% CI, 1.22-1.79; P < .001, respectively). Hispanic patients had greater risk of all-cause mortality (HR, 2.41; 95% CI, 1.24-4.70; P = .01) and higher odds of a 30-day major adverse event (odds ratio, 1.92; 95% CI, 1.38-2.68; P < .001) for RYGB compared with SG. There was no interaction between race and ethnicity and operation type for diabetes remission and relapse.Conclusions and Relevance: Variability of the comparative effectiveness of operations for %TWL and HbA1c level across race and ethnicity was clinically small; however, differences in safety and utilization outcomes were clinically and statistically significant for Black and Hispanic patients who had RYGB compared with SG. These findings can inform shared decision-making regarding bariatric operation choice for different racial and ethnic groups of patients.

3 August 2020 in Obesity Surgery
Verified
Journal Article
Closed access
PDF file
HAHassan Aliakbarian
Hassan Aliakbarian
HBHina Y. Bhutta
Hina Y. Bhutta
KHKeyvan Heshmati
Keyvan Heshmati
SKShebna Unes Kunju
Shebna Unes Kunju
ESEric G. Sheu
Eric G. Sheu
ATAli Tavakkoli
Ali Tavakkoli

1 April 2020 in Surgery
Verified
Journal Article
Closed access
JJJoshua Jolissaint
Joshua Jolissaint
BDBryan V. Dieffenbach
Bryan V. Dieffenbach
TTThomas C. Tsai
Thomas C. Tsai
LPLuise I. Pernar
Luise I. Pernar
BSBrent T. Shoji
Brent T. Shoji
ATAli Tavakkoli
Ali Tavakkoli

27 August 2018 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
RSReuben D. Shin
Reuben D. Shin
RLRoger Lis
Roger Lis
NLNicholas R. Levergood
Nicholas R. Levergood
DBDavid C. Brooks
David C. Brooks
BSBrent T. Shoji
Brent T. Shoji
ATAli Tavakkoli
Ali Tavakkoli